<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ma T</submitter><funding>National Natural Science Foundation of China</funding><funding>Zhejiang Province Natural Science Foundation</funding><pagination>171-188</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12005309</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>50</volume><pubmed_abstract>The onset of periprosthetic osteolysis is mediated by wear particles following artificial arthroplasty. This manifests as a disturbed bone metabolism microenvironment, characterized by insufficient osteogenesis and angiogenesis, and enhanced osteoclastic activity. To target and remodel the homeostatic environment of bone metabolism in the sterile region around the prosthesis, we successfully pioneered the proposal and construction of a fused exosome (f-exo) system with M2 macrophage-derived exosomes (M2-exo) and urine-derived stem cell exosomes (USC-exo). The results demonstrate that f-exo effectively combines the osteolysis region-targeting capabilities of M2-exo with the bone metabolic homeostasis modulation effects of two exosomes (M2-exo and USC-exo), thereby achieving a significantly </pubmed_abstract><journal>Bioactive materials</journal><pubmed_title>Fused exosomal targeted therapy in periprosthetic osteolysis through regulation of bone metabolic homeostasis.</pubmed_title><pmcid>PMC12005309</pmcid><funding_grant_id>82272452</funding_grant_id><funding_grant_id>LQN25H060009</funding_grant_id><funding_grant_id>82202733</funding_grant_id><funding_grant_id>82372414</funding_grant_id><pubmed_authors>Yang Y</pubmed_authors><pubmed_authors>Hu Y</pubmed_authors><pubmed_authors>Zhang Z</pubmed_authors><pubmed_authors>Xie J</pubmed_authors><pubmed_authors>Liu Q</pubmed_authors><pubmed_authors>Ma T</pubmed_authors><pubmed_authors>Nan J</pubmed_authors><pubmed_authors>Liu G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Fused exosomal targeted therapy in periprosthetic osteolysis through regulation of bone metabolic homeostasis.</name><description>The onset of periprosthetic osteolysis is mediated by wear particles following artificial arthroplasty. This manifests as a disturbed bone metabolism microenvironment, characterized by insufficient osteogenesis and angiogenesis, and enhanced osteoclastic activity. To target and remodel the homeostatic environment of bone metabolism in the sterile region around the prosthesis, we successfully pioneered the proposal and construction of a fused exosome (f-exo) system with M2 macrophage-derived exosomes (M2-exo) and urine-derived stem cell exosomes (USC-exo). The results demonstrate that f-exo effectively combines the osteolysis region-targeting capabilities of M2-exo with the bone metabolic homeostasis modulation effects of two exosomes (M2-exo and USC-exo), thereby achieving a significantly </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Aug</publication><modification>2025-07-08T03:11:35.256Z</modification><creation>2025-07-08T03:11:35.256Z</creation></dates><accession>S-EPMC12005309</accession><cross_references><pubmed>40248188</pubmed><doi>10.1016/j.bioactmat.2025.04.006</doi></cross_references></HashMap>